The U.S. Supreme Court’s holdings in several ventures, along with recent decisions by the U.S. Court of Appeals for the Federal Circuit, and non-binding USPTO examination guidelines have drastically altered expectations regarding patent-eligible subject matter. In this IP Flash article from the spring edition of European Biotechnology, Judith U. Kim, and Scott A. Schaller, Ph.D., discuss transformative subject matter patent-eligibility in the United States.

To read the article, please download the attached PDF.